MedPath

The Effect of Standardizing Procedures for SC Injections of LMWH on Patients with CVD

Not Applicable
Not yet recruiting
Conditions
CVD - Cardiovascular Disease
Bruise
Pain
Registration Number
NCT06776159
Lead Sponsor
The Hong Kong Polytechnic University
Brief Summary

Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.

Detailed Description

This study examines the effect of standardized protocol in reducing complications for patients with cardiovascular disease.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
180
Inclusion Criteria
  • patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day
  • Chinese
Exclusion Criteria
  • cognitively impaired
  • unconscious
  • refuse to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Bruising24 hours, 48 hours, 72 hours

The bruising diameter will be measured by a ruler and the incidence of bruising will be recorded.

PainImmediately after injection, 24 hours, 48 hours, 72 hours

Patients' pain level is measured by Verbal Descriptor Scale from zero to ten. Higher the score means a worse outcome.

Secondary Outcome Measures
NameTimeMethod
Patient ExperienceImmediately after receiving the injection

a Patient Experience Surveys to evaluate their perceived nurse's attitude

Communicative CompetenceImmediately before and after injection

Communicative Competence Scale consists of 36 items across five dimensions (General Competence, Empathy Affiliation/Support, Behavioural Flexibility, and Social Relaxation), using a 5-point Likert scales ranging from strongly agree to strongly disagree (coded from 1 to 5). Higher the score means worse the outcome.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.